logo
logo

Signifier Medical Technologies Raises $35M In Series D Funding Round To Accelerate Commercialization Of Exciteosa Therapy

Jul 27, 2021•about 4 years ago

Amount Raised

$35 Million

Round Type

series d

Boston

Description

Signifier Medical Technologies Ltd, a pioneer in patient-friendly therapies for sleep disordered breathing, announced that it has successfully raised $35 million in its Series D capital raise. This financing will underpin the commercialization of Signifier’s FDA-approved De Novo device and therapy, eXciteOSA®, to treat millions of patients around the world suffering from primary snoring and mild obstructive sleep apnea (OSA).

Company Information

Company

Signifier Medical Technologies

Location

Boston, Massachusetts, United States

About

Signifier Medical Technologies is a pioneer in understanding and addressing the root causes of sleep disordered breathing. We are focused on the development and commercialization of innovative and non-invasive solutions for patients with conditions such as OSA and primary snoring. Founded in 2015, Signifier Medical Technologies is at the forefront of sleep therapy, focused on developing therapies that put patient experience and comfort first. Signifier has offices in London (UK), Needham (Massachusetts, USA) and Berlin (Germany).

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech